Delivery Order SPE2DB20D7059-SPE2DB25FGSX5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,011.54 to AmerisourceBergen Drug Corp for the supply of Junel FE 1.5 mg-30 mcg tablets in a 28-count package. This competitively awarded, firm fixed-price contract was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,570.36 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets (28-count packages). This firm fixed price, non-set-aside delivery order is scheduled for completion by August 20, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $1,065.18 to AmerisourceBergen Drug Corp for the supply of Junel FE 1.5 mg-30 mcg tablets (28-count packages) under a firm fixed-price arrangement. The award, issued on May 21, 2025, with an ultimate completion date of May 22, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.20 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages). This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and has an ultimate completion date of August 25, 2025. The delivery order was issued on August 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 tablets, with a contract ceiling value of $1,201.82. This firm fixed-price delivery order, which is expected to be completed by August 27, 2025, represents a competitively awarded, non-set-aside procurement with performance taking place at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a $1,071.66 delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader contract vehicle with DLA....
- The Defense Logistics Agency awarded a delivery order valued at $5,800.03 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) on September 8, 2025, with completion expected by September 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is classified as a child contract under a larger vehicle. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,587.38 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) on August 11, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by August 12, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader relationship with the federal government for...
- The Defense Logistics Agency awarded a $2,046.60 delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg–20 mcg tablets (28-count packages) on July 3, 2025, with a ceiling value of $1,142.76 and an ultimate completion date of July 7, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The product will be delivered to the company's...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGSX5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Junel FE 1.5 mg-30 mcg tablets (28-count package) valued at $1,422.36. This competitive, non-set-aside contract was executed on September 23, 2025, with an ultimate completion date of September 24, 2025, utilizing firm fixed pricing. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a diverse portfolio of medications and medical supplies to support military and veteran healthcare systems. The company's extensive contract awards with the Defense Logistics Agency and Medical Supply Chain demonstrate its established capability to fulfill federal pharmaceutical requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices for defense and healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/23/25 |